# PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma

> **NCT01393912** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 55 (actual)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma
- Progressive or Refractory High-Grade Glioma

## Interventions

- **DRUG:** Crenolanib

## Key facts

- **NCT ID:** NCT01393912
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-09
- **Final completion:** 2016-10
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-04-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393912, "PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01393912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*